A study of a branded beta-alanine product (CarnoSyn) found muscle carnosine rose 58.8% at 4 weeks and 80.1% at 10 weeks, with a corresponding 13.0% increase in high-intensity cycling work capacity at 4 weeks and a further 3.2% at 10 weeks; no change occurred in placebo recipients. These outcomes do not establish benefits for every exercise task or long-term health, and random allocation is not described in the inspected record.[1]
- Small study with fewer participants completing later testing; random allocation is not described and PubMed's own index does not tag this record as a randomized controlled trial; findings are specific to the branded CarnoSyn product.
- Abstract-checked; no qualified clinical review.
Inspection history
Clinical review: not reviewed by a qualified clinician.
· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.
· Reopened the PubMed structured abstract via E-utilities, added exact carnosine/work-capacity percentage changes, identified the branded product (CarnoSyn), and confirmed no Randomized Controlled Trial publication-type tag. No PMC full text available. Independent editorial review pending; no qualified clinical review.